| The internationalization of ayahuasca B Labate, H Jungaberle LIT Verlag Münster, 2011 | 257 | 2011 |
| Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review S Reiche, L Hermle, S Gutwinski, H Jungaberle, P Gasser, T Majić Progress in Neuropsychopharmacology and Biological Psychiatry 81, 1-10, 2018 | 141 | 2018 |
| Development of risk perception and substance use of tobacco, alcohol and cannabis among adolescents and emerging adults: evidence of directional influences D Grevenstein, E Nagy, H Kroeninger-Jungaberle Substance use & misuse 50 (3), 376-386, 2015 | 138 | 2015 |
| Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance M Wolff, R Evens, LJ Mertens, M Koslowski, F Betzler, G Gründer, ... Frontiers in psychiatry 11, 5, 2020 | 122 | 2020 |
| Psychedelic microdosing: a subreddit analysis T Lea, N Amada, H Jungaberle Journal of Psychoactive Drugs 52 (2), 101-112, 2020 | 112 | 2020 |
| Microdosing psychedelics: Motivations, subjective effects and harm reduction T Lea, N Amada, H Jungaberle, H Schecke, M Klein International Journal of Drug Policy 75, 102600, 2020 | 94 | 2020 |
| Positive psychology in the investigation of psychedelics and entactogens: A critical review H Jungaberle, S Thal, A Zeuch, A Rougemont-Bücking, M von Heyden, ... Neuropharmacology 142, 179-199, 2018 | 79 | 2018 |
| Development of salutogenetic factors in mental health–-Antonovsky’s sense of coherence and Bandura’s self-efficacy related to Derogatis’ symptom check list (SCL-90-R) H Kröninger-Jungaberle, D Grevenstein Health and quality of life outcomes 11 (1), 80, 2013 | 67 | 2013 |
| Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders T Lea, N Amada, H Jungaberle, H Schecke, N Scherbaum, M Klein Psychopharmacology 237, 1521-1532, 2020 | 66 | 2020 |
| Incremental validity of sense of coherence, neuroticism, extraversion, and general self-efficacy: Longitudinal prediction of substance use frequency and mental health D Grevenstein, M Bluemke, H Kroeninger-Jungaberle Health and Quality of Life Outcomes 14, 1-14, 2016 | 62 | 2016 |
| Subjective theories about (self‐) treatment with ayahuasca JT Schmid, H Jungaberle, R Verres Anthropology of Consciousness 21 (2), 188-204, 2010 | 61 | 2010 |
| An epidemiogical surveillance system by the UDV: Mental health recommendations concerning the religious use of hoasca LF Tófoli The internationalization of ayahuasca, 185-200, 2011 | 43 | 2011 |
| Sense of coherence and substance use: Examining mutual influences D Grevenstein, M Bluemke, E Nagy, CEM Wippermann, ... Personality and individual Differences 64, 52-57, 2014 | 37 | 2014 |
| Therapie mit psychoaktiven Substanzen: Praxis und Kritik der Psychotherapie mit LSD, Psilocybin und MDMA H Jungaberle, P Gasser, J Weinhold, R Verres Hans-Huber Verlag, 2008 | 35* | 2008 |
| Handbuch Psychoaktive Substanzen M Von Heyden, H Jungaberle, T Majić Springer Berlin Heidelberg, 2018 | 28 | 2018 |
| REBOUND: A media-based life skills and risk education programme H Kröninger-Jungaberle, E Nagy, M von Heyden, F DuBois Health Education Journal, 2014 | 25 | 2014 |
| New steps in musical meaning–The metaphoric process as an organizing principle H Jungaberle, R Verres, F DuBois Nordic Journal of Music Therapy 10 (1), 4-16, 2001 | 25 | 2001 |
| The potential role of psychedelic drugs in mental health care of the future G Gründer, H Jungaberle Pharmacopsychiatry 54 (04), 191-199, 2021 | 23 | 2021 |
| "Töne strömen ein". Beiträge zur Musikpsychologie des Monochords H Jungaberle, P Altieri, E Gerloff, K Kurze, R Verres Musiktherapeutische Umschau 24 (3), 319-332, 2002 | 20* | 2002 |
| Treatment with psychedelics is psychotherapy: beyond reductionism G Gründer, M Brand, LJ Mertens, H Jungaberle, L Kärtner, DJ Scharf, ... The Lancet Psychiatry 11 (3), 231-236, 2024 | 19 | 2024 |
Gerhard GründerProfessor of Psychiatry, Central Institute of Mental Health在 zi-mannheim.de 的电子邮件经过验证
